To reinforce their commitment to enable universal access, Biocon is making recombinant human insulin available at less than 10 cents per day in low- and middle-income countries (LMICs). At 10 cents a day, their insulin could be a game changer for patients who currently pay almost three times the price for the therapy in LMICs.

Check out the website:
https://www.biocon.com/10-c-answer-to-diabetes/